AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma AVEO Oncology and Astellas Pharma Inc. today announced that AVEO provides submitted a fresh Drug Program to the U sildenafil .S. Food and Drug Administration seeking approval for tivozanib in individuals with advanced renal cell carcinoma . Tivozanib is certainly designed to target the vascular endothelial growth factor pathway, a validated target in RCC and various other solid tumors clinically.
AUA clarifes recommendations on prostate cancer testing with PSA DRE and test The American Urological Association is aware of recent news reports disparaging prostate cancer testing. We are worried that these reports are causing significant misunderstandings for sufferers and we desire to clarify our recommendations on prostate cancers tests with the prostate-specific antigen ensure that you digital rectal exam . The AUA highly supports early prostate tumor recognition and feels it is in a man’s greatest interest to consider being tested for prostate cancers. Prostate cancer is usually most treatable when caught early.